ASX Equity Snapshot

NEU Weekly Equity Report

Neuren Pharmaceuticals Limited

Interactive chart JSON snapshot
Latest Close 13.39 AUD 12 Jun 2026
1W Return -1.9% latest completed week
4W Return 4.7% short-term follow-through
12W Return 16.7% quarterly tape
Trend Breadth 55.8% 29 of 52 weeks active
Volume Ratio 0.6x vs 13-week average
Company Brief

What the company does

Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders. It develops and commercializes DAYBUE (trofinetide) for the treatment of Rett syndrome in adults and pediatric patients 2 years of age and older, as well as in Phase 2 clinical trial to treat Fragile X syndrome. The company also develops NNZ-2591, which has completed Phase 2 clinical trial for the treatment of Phelan-McDermid; and in Phase 2 clinical trial for the treatment of Angelman and Pitt Hopkins. In addition, it develops NNZ-2591, which is in preclinical trial stage for the treatment …

Snapshot

What the weekly tape is saying

NEU closed the latest completed week at 13.39 AUD. The 4-week return is 4.7% and the 12-week return is 16.7%. Trend Signal is inactive, Market Dynamics is 0.52. Setup signature: Risk-first tape with a 37/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -10.5%
Volume 0.6x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 31 Persistence of active Trend Signal over the last year and current streak.
Momentum 76 Blend of 4-week and 12-week follow-through.
Dynamics 87 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 0 Relative leadership and short-term RS change.
Volume 27 Participation compared with the 13-week volume baseline.
Risk Control 0 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
14.96 AUD
Vs Trend Line
-10.5%
Fair Value
15.81 AUD
Vs Fair Value
-15.3%
52W High
22.99 AUD
52W Low
11.00 AUD
Drawdown
-41.7%
Range Position
19.9%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -1.9%
4W 4.7%
12W 16.7%
26W -29.6%
52W 2.2%

Trend read

Active Streak
0 weeks
52W Active Weeks
29
52W Active Breadth
55.8%
Sector Scope
AU Healthcare
Sector Rank
80 of 146
Sector Percentile
45.5%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
0.52
4W MD Change
344.1%
Relative Strength
-18.07
4W RS Change
10.4%
Expectation
Undecided
Probability
48.26%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
1.1M
13W Average
1.8M
52W Average
2.2M
Vs 13W
0.6x
Vs 52W
0.5x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
3.5%
52W Volatility
6.3%
Upside Weeks
29
Downside Weeks
23
Downside Breadth
44.2%
Avg Gain / Loss
4.3% / -4.9%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
ASX
Country
AU
Sector
Healthcare
Industry
Biotechnology
Currency
AUD
Market Cap
1.8B

Opportunity signals

  • Market Dynamics is positive on the latest completed week.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 13.39 AUD -1.9% 14.96 AUD 15.81 AUD 0.52 -18.07 1.1M Off
5 Jun 2026 13.65 AUD -6.1% 15.15 AUD 15.80 AUD 0.53 -14.76 1.5M Off
29 May 2026 14.54 AUD 6.4% 15.31 AUD 15.80 AUD 0.42 -10.34 1.7M Off
22 May 2026 13.67 AUD 6.9% 15.55 AUD 15.79 AUD 0.14 -14.96 1.5M Off
15 May 2026 12.79 AUD -0.1% 15.81 AUD 15.79 AUD -0.21 -20.16 1.8M Off
8 May 2026 12.80 AUD 2.6% 16.07 AUD 15.80 AUD -0.62 -21.22 1.8M Off
1 May 2026 12.47 AUD 1.1% 16.36 AUD 15.81 AUD -0.97 -23.24 1.4M Off
24 Apr 2026 12.33 AUD -1.3% 16.66 AUD 15.82 AUD -1.25 -24.66 1.2M Off
17 Apr 2026 12.49 AUD -0.2% 16.90 AUD 15.83 AUD -1.37 -25.06 1.4M Off
10 Apr 2026 12.52 AUD 4.1% 17.14 AUD 15.84 AUD -1.36 -24.96 1.2M Off
3 Apr 2026 12.03 AUD 2.1% 17.37 AUD 15.84 AUD -1.33 -24.54 1.7M Off
27 Mar 2026 11.78 AUD 2.7% 17.65 AUD 15.85 AUD -1.29 -25.47 2.6M Off
20 Mar 2026 11.47 AUD -2.5% 17.89 AUD 15.86 AUD -1.27 -26.79 4.4M Off
13 Mar 2026 11.76 AUD -4.8% 18.08 AUD 15.87 AUD -1.33 -26.75 3.3M Off